An important piece of information that we lack is an accurate picture of the current spread of COVID-19. One way to get that information is to deploy widespread and high-quality serologic antibody testing.
In the past, the development of antimicrobial stewardship efforts mainly focused on prescribers and pharmacists. Today, as the threat of AMR increases, there is growing recognition of the need for efforts to also focus on other stakeholders in antibiotic use—particularly nurses
The world at large is having to abide by social distancing orders amidst COVID-19, which is something that individuals with CF have been experiencing to some degree for much of their lives to protect their health.
It is especially important to focus on prevention methods amid the COVID-19 pandemic—in previous reports of SARS and MERS-CoV infections, AKI developed in 5% to 15% of cases and carried an extremely high (60%-90%) mortality rate.